Papers
1
Total Citations
14
H-Index
1
About
Dr. Takeshi Tomonaga is a leading figure in clinical proteomics and extracellular vesicle (EV) research, with a focus on developing cutting-edge methodologies for biomarker discovery. His major contributions center on advancing automated proteomics workflows to isolate and analyze phosphatidylserine-positive EVs from human body fluids, a critical step for translating EV-based diagnostics into clinical practice. His 2022 paper on this topic has already garnered 14 citations, reflecting its immediate impact in the field. By streamlining sample preparation, Dr. Tomonaga enables more reliable and high-throughput proteomic profiling of blood-derived EVs, which hold immense promise as non-invasive biomarkers for diseases such as cancer. His work bridges the gap between complex proteomic technologies and practical clinical applications, making him a key innovator in the drive toward precision medicine. For students and researchers, Dr. Tomonaga’s research exemplifies how technical refinement in proteomics can unlock the diagnostic potential of extracellular vesicles, paving the way for earlier disease detection and personalized treatment strategies.
Research Focus
Key Achievements
Top Papers
- 1